White House backs off ‘backdoor rebate’ idea for lowering drug prices

Published



The White House has thrown out a plan to upend the drug pricing rebate model that President Trump’s health chief once said could be the “most significant change” in how medicines are priced.

Judd Deere, White House spokesman, said that the idea was pulled by Trump “based on careful analysis and thorough consideration.”

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.